A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00144482
Recruitment Status : Completed
First Posted : September 5, 2005
Last Update Posted : February 2, 2009
Information provided by:
Chugai Pharmaceutical

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : March 2005
  Study Completion Date : August 2005